Literature DB >> 10951445

Anti-GM1 antibodies can block neuronal voltage-gated sodium channels.

F Weber1, R Rüdel, P Aulkemeyer, H Brinkmeier.   

Abstract

Anti-GM1 antibodies, frequently found in the serum of patients with Guillain-Barré syndrome (GBS), have been suggested to interfere with axonal function. We report that IgG anti-GM1 antibodies, raised in rabbits, can reversibly block the voltage-gated Na(+) channels of nerve cells, thus causing a reduction of the excitatory Na(+) current. The block was, however, only substantial when the antibodies were applied together with rabbit complement factors. A solution containing anti-GM1 sera (dilution 1:100) and complement (1:50) reduced the Na(+) current to 0.5 +/- 0.2 times control (mean value +/- SD). Applications of the antibody by itself, complement by itself, or anti-GM2 or anti-GM4 antibodies (1:100) plus complement had little effect. The complexes of anti-GM1 antibodies and complement factors block the ion-conducting pore of the channel directly. In addition, they increase the fraction of channels that are inactivated at the resting potential and alter channel function by changing the membrane surface charge. The described effects may be responsible for conduction slowing and reversible conduction failure in some GBS patients. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951445     DOI: 10.1002/1097-4598(200009)23:9<1414::aid-mus13>3.0.co;2-0

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Neurophysiological and immunohistochemical studies of IgG anti-GM1 monoclonal antibody on neuromuscular transmission: effects in rat neuromuscular junctions.

Authors:  Sayako Hotta; Takumi Nagaoka; Kyoji Taguchi; Yoshihiko Nakatani; Iku Utsnomiya; Yutaka Masuda; Kenji Abe; Nobuhiro Yuki
Journal:  Neurol Sci       Date:  2013-07-03       Impact factor: 3.307

2.  Mosquitocidal properties of IgG targeting the glutamate-gated chloride channel in three mosquito disease vectors (Diptera: Culicidae).

Authors:  Jacob I Meyers; Meg Gray; Brian D Foy
Journal:  J Exp Biol       Date:  2015-05-15       Impact factor: 3.312

Review 3.  The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis.

Authors:  Pablo H H Lopez; Ricardo D Lardone; Fernando J Irazoqui; Mariana Maccioni; Gustavo A Nores
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.

Authors:  Yoshihiko Nakatani; Sayako Hotta; Iku Utsunomiya; Keiko Tanaka; Keiko Hoshi; Toshi Ariga; Robert K Yu; Tadashi Miyatake; Kyoji Taguchi
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

5.  Normally occurring human anti-GM1 immunoglobulin M antibodies and the immune response to bacteria.

Authors:  María E Alaniz; Ricardo D Lardone; Silvia L Yudowski; María I Farace; Gustavo A Nores
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

6.  No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies.

Authors:  David J Wang; David A Boltz; Janet McElhaney; Jonathan A McCullers; Richard J Webby; Robert G Webster
Journal:  Influenza Other Respir Viruses       Date:  2011-09-29       Impact factor: 4.380

Review 7.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

8.  Dysfunction of Corticomotoneurons in Guillain-Barré Syndrome (GBS)?

Authors:  Steve Vucic
Journal:  Clin Med Case Rep       Date:  2009-10-01

Review 9.  Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.

Authors:  Ariel D Stock; Jing Wen; Chaim Putterman
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

10.  Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.

Authors:  C W Ang; P G Noordzij; M A de Klerk; H P Endtz; P A van Doorn; J D Laman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.